69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] VICCURO1473 01/09/2015 [Summary] A Randomized Phase II Study of Androgen Deprivation Therapy with or without PD 0332991 in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer. [Trial Type] 
Treatment Prostate
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type